Pune-Based Gennova Biopharmaceuticals Developing Vaccine For Omicron: Why This Could Be A Game Chang
[email protected]24 Feb, 2022News
As Omicron rages across India, causing a spike in COVID-19 cases, Pune's Gennova Biopharmaceuticals is developing an Omicron-specific vaccine. The company, according to a spokesperson, has already filed its phase 2 data with Central Drugs Standard Control Organisation (CDSCO). "Gennova Biopharmaceuticals had filed its phase 2 data with CDSCO on Friday. The Omicron specific variant of vaccine is under development and will be ready for human clinical trials, subject to regulatory approvals," news agency ANI quoted the spokesperson of Gennova Biopharmaceuticals as saying. Here?s what we know so far about this new vaccine.
Related Bookmarks
- Preschool Corte Madera
- Shared Services operate with a mindset of a business and views other organizations as customers
- Valves are devices that regulate the flow of fluids by opening and closing
- Apple Unterst�tzung Berlin
- Get the Benefits For Garage Door Repair in Markham
- Antimicrobial Additives are antimicrobial agents that inhibit and prevent germs
- Peer-to-peer lending is an alternative to traditional banks
- Kia Carens Specifications
- 10 Most In-Demand Business to Open in Florida that Ordinary People Should Know in 2022
- What You Don�t Know About Computer Repair in Cardiff
Recent Profiles
Hitclub
Dr. Geetanjali Saxena
Cascadia Spray Foam Of Seattle
Arthor Smith
Electric Dab Rig
Sao789
39betjpncom
Male Massages London
Belt And Road Portal
Blo Cycles